Roche Holding Correlations
| RHO6 Stock | EUR 39.65 0.50 1.25% |
The current 90-days correlation between Roche Holding and Harmony Gold Mining is 0.12 (i.e., Average diversification). The correlation of Roche Holding is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Roche Holding Correlation With Market
Good diversification
The correlation between Roche Holding Ltd and DJI is -0.11 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Roche Holding Ltd and DJI in the same portfolio, assuming nothing else is changed.
Roche |
The ability to find closely correlated positions to Roche Holding could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Roche Holding when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Roche Holding - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Roche Holding Ltd to buy it.
Moving together with Roche Stock
| 0.7 | JNJ | Johnson Johnson | PairCorr |
| 0.95 | AMG | Amgen Inc | PairCorr |
| 0.83 | BAYN | Bayer AG NA | PairCorr |
| 0.75 | BAYA | Bayer Aktiengesellschaft | PairCorr |
| 0.63 | CJH | CanSino Biologics | PairCorr |
| 0.83 | WY8 | Universal Health Realty | PairCorr |
| 0.63 | RHM | Rheinmetall AG | PairCorr |
| 0.73 | E908 | Lyxor 1 | PairCorr |
| 0.73 | DBPE | Xtrackers LevDAX | PairCorr |
Moving against Roche Stock
| 0.76 | DBPD | Xtrackers ShortDAX | PairCorr |
| 0.72 | 6MK | Merck | PairCorr |
| 0.7 | PQ9 | PT Bank Mandiri | PairCorr |
| 0.68 | BZG2 | BANK CENTRAL ASIA | PairCorr |
| 0.64 | PQ9 | BANK MANDIRI | PairCorr |
| 0.63 | BZG2 | BANK CENTRAL ASIA | PairCorr |
| 0.62 | PQ9 | BANK MANDIRI | PairCorr |
| 0.56 | PQ9 | BANK MANDIRI | PairCorr |
| 0.54 | BYRA | BANK RAKYAT IND | PairCorr |
| 0.5 | IDP | Biogen Inc | PairCorr |
| 0.5 | BYRA | PT Bank Rakyat | PairCorr |
| 0.47 | I7G | Ipsen SA | PairCorr |
| 0.39 | YPH | Astellas Pharma | PairCorr |
| 0.34 | BYRA | BANK RAKYAT IND | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Roche Stock performing well and Roche Holding Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Roche Holding's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 6C2 | 3.14 | 0.54 | 0.17 | 0.47 | 2.98 | 7.84 | 25.40 | |||
| WCLA | 2.22 | 0.43 | 0.17 | 4.99 | 2.40 | 5.71 | 14.25 | |||
| I43 | 1.73 | 0.35 | 0.20 | (0.96) | 1.87 | 4.07 | 18.36 | |||
| M1W | 3.51 | 0.49 | 0.11 | (0.82) | 3.22 | 5.56 | 27.08 | |||
| 2U0 | 2.41 | 0.29 | 0.14 | (1.35) | 2.25 | 5.80 | 24.27 | |||
| WB2 | 1.26 | (0.15) | 0.00 | 3.39 | 0.00 | 2.38 | 11.07 | |||
| 5PMA | 2.98 | 0.37 | 0.11 | (2.14) | 2.99 | 6.52 | 20.17 | |||
| HAM | 2.40 | 0.45 | 0.18 | 8.72 | 2.48 | 5.94 | 12.60 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Roche Holding without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
| All Next | Launch Module |
Roche Holding Corporate Management
Elected by the shareholders, the Roche Holding's board of directors comprises two types of representatives: Roche Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Roche. The board's role is to monitor Roche Holding's management team and ensure that shareholders' interests are well served. Roche Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Roche Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Claudia Bockstiegel | G Counsel | Profile | |
| Barbara Schadler | Head Communications | Profile | |
| Johannes MD | Head Devel | Profile | |
| Bruno Eschli | Head Relations | Profile | |
| Thomas Schinecker | Chief Diagnostics | Profile | |
| Cristina Wilbur | Chief Officer | Profile | |
| William Anderson | Chief Pharmaceuticals | Profile |